Biallelic CXCR2 loss-of-function mutations define a distinct congenital neutropenia entity

Haematologica. 2022 Mar 1;107(3):765-769. doi: 10.3324/haematol.2021.279254.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Congenital Bone Marrow Failure Syndromes* / diagnosis
  • Congenital Bone Marrow Failure Syndromes* / genetics
  • Humans
  • Loss of Function Mutation
  • Neutropenia* / congenital
  • Neutropenia* / diagnosis
  • Neutropenia* / genetics
  • Receptors, Interleukin-8B / genetics*

Substances

  • CXCR2 protein, human
  • Receptors, Interleukin-8B

Supplementary concepts

  • Neutropenia, Severe Congenital, Autosomal Recessive 3

Grants and funding

Funding: the French Severe Chronic Neutropenia Registry is supported by grants from X4 Pharma, Prolong Pharma and Chugai SA (B. Beaupain, J. Donadieu). This work was also funded by the Association Laurette Fugain and the CEREDIH.